Turn Therapeutics (TTRX) Non-Current Assets (2024 - 2026)

Turn Therapeutics' Non-Current Assets history runs 3 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• On a quarterly basis, Non-Current Assets changed N/A year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.0 million, up 632.5% from the prior year.
• Non-Current Assets advanced to $7.2 million in Q1 2026 per TTRX's latest filing, from $7.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $7.2 million in Q1 2026 and bottomed at $950965.0 in Q4 2024.
• The 3-year median for Non-Current Assets is $4.0 million (2025), against an average of $4.0 million.
• Biggest YoY gain for Non-Current Assets was 632.5% in 2025; the steepest drop was 632.5% in 2025.
• Year by year, Non-Current Assets stood at $950965.0 in 2024, then jumped by 632.5% to $7.0 million in 2025, then rose by 3.24% to $7.2 million in 2026.
• Per Business Quant, the three latest TTRX Non-Current Assets figures stand at $7.2 million (Q1 2026), $7.0 million (Q4 2025), and $1.0 million (Q3 2025).